147 related articles for article (PubMed ID: 28693293)
1. MAPK inhibitors enhance cell death in pyrogallol-treated human pulmonary fibroblast cells via increasing O
Han BR; Park WH
Oncol Lett; 2017 Jul; 14(1):1179-1185. PubMed ID: 28693293
[TBL] [Abstract][Full Text] [Related]
2. Pyrogallol induces the death of human pulmonary fibroblast cells through ROS increase and GSH depletion.
Park WH
Int J Oncol; 2016 Aug; 49(2):785-92. PubMed ID: 27278810
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
Park WH
Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
[TBL] [Abstract][Full Text] [Related]
4. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
Park WH
Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
[TBL] [Abstract][Full Text] [Related]
5. Effects of antioxidants and MAPK inhibitors on cell death and reactive oxygen species levels in H
Park WH
Oncol Lett; 2013 May; 5(5):1633-1638. PubMed ID: 23760725
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park WH
Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
[TBL] [Abstract][Full Text] [Related]
7. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.
Han YH; Park WH
Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265
[TBL] [Abstract][Full Text] [Related]
8. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Park WH
Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
[TBL] [Abstract][Full Text] [Related]
9. JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2009 Nov; 24(5):717-22. PubMed ID: 19787207
[TBL] [Abstract][Full Text] [Related]
10. Propyl gallate induces cell death in human pulmonary fibroblast through increasing reactive oxygen species levels and depleting glutathione.
Park WH
Sci Rep; 2024 Mar; 14(1):5375. PubMed ID: 38438412
[TBL] [Abstract][Full Text] [Related]
11. Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3.
Park WH
Ann Med; 2024 Dec; 56(1):2319853. PubMed ID: 38373208
[TBL] [Abstract][Full Text] [Related]
12. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.
Park WH
Mol Med Rep; 2011; 4(1):193-04. PubMed ID: 21461585
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
You BR; Park WH
Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
[TBL] [Abstract][Full Text] [Related]
14. Antimycin A induces death of the human pulmonary fibroblast cells via ROS increase and GSH depletion.
Park WH; You BR
Int J Oncol; 2016 Feb; 48(2):813-20. PubMed ID: 26647857
[TBL] [Abstract][Full Text] [Related]
15. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
Park WH
Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
[TBL] [Abstract][Full Text] [Related]
16. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
Park WH; Kim SH
Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922
[TBL] [Abstract][Full Text] [Related]
17. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
Park WH
Oncol Rep; 2018 Feb; 39(2):860-870. PubMed ID: 29207156
[TBL] [Abstract][Full Text] [Related]
18. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
You BR; Park WH
J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
[TBL] [Abstract][Full Text] [Related]
19. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
Han YH; Kim SH; Kim SZ; Park WH
Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
[TBL] [Abstract][Full Text] [Related]
20. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
Park WH; Kim SH
Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
